Umecrine Cognition AB

Patent Applications and Registrations

Patent applications and USPTO patent grants for Umecrine Cognition AB.The latest application filed is for "pharmaceutical formulation of 3-alpha-ethynyl-3-beta-hydroxyandrostan-17-one oxime".

Company Profile

12.14.10

Umecrine Cognition AB - Solna SE
UMECRINE COGNITION AB - Stockholm SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical formulation of 3-alpha-ethynyl-3-beta-hydroxyandrostan-17-one oxime Grant 11,123,351 - Alhadeff , et al. September 21, 2	2021-09-21
Pharmaceutical Formulation Of 3-alpha-ethynyl-3-beta-hydroxyandrostan-17-one Oxime App 20200297737 - Alhadeff; Paul ; et al.	2020-09-24
Pharmaceutical formulation of 3.alpha.-ethynyl-3.beta.-hydroxyandrostan-17-one oxime Grant 10,603,326 - Alhadeff , et al.	2020-03-31
Pharmaceutical Formulation Of 3alpha -ethynyl-3beta-hydroxyandrostan-17-one Oxime App 20190358244 - Alhadeff; Paul ; et al.	2019-11-28
3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders Grant 10,351,589 - Backstrom , et al. July 16, 2	2019-07-16
Steroid compound for use in the treatment of hepatic encephalopathy Grant 10,342,804 - Doverskog , et al. July 9, 2	2019-07-09
Methods for treating hypersomnolence Grant 10,278,977 - Backstrom , et al.	2019-05-07
Steroid Compound For Use In The Treatment Of Hepatic Encephalopathy App 20180015103 - Doverskog; Magnus ; et al.	2018-01-18
3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime For Use In The Treatment Of Cns Disorders App 20170369522 - Backstrom; Torbjorn ; et al.	2017-12-28
Methods And Medical Uses App 20170348323 - Backstrom; Torbjorn ; et al.	2017-12-07
Steroid compound for use in the treatment of hepatic encephalopathy Grant 9,801,894 - Doverskog , et al. October 31, 2	2017-10-31
Steroid Compound For Use In The Treatment Of Hepatic Encephalopathy App 20170056416 - Doverskog; Magnus ; et al.	2017-03-02
Steroid Compound For Use In The Treatment Of Hepatic Encephalopathy App 20160339040 - Doverskog; Magnus ; et al.	2016-11-24
Steroids Having Increased Water Solubility And Resistance Against Metabolism And Methods For Their Production App 20160272670 - Backstrom; Torbjorn ; et al.	2016-09-22
Steroids having increased water solubility and resistance against metabolism and methods for their production Grant 9,200,028 - Backstrom , et al. December 1, 2	2015-12-01
Pregnane Steroids And Their Use In The Treatment Of Cns Disorders App 20110098259 - Backstrom; Torbjorn ; et al.	2011-04-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.